SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-027122
Filing Date
2023-08-08
Accepted
2023-08-08 10:30:28
Documents
28
Period of Report
2023-08-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50408
2 ex10-1.htm EX-10.1 11130
3 ex99-1.htm EX-99.1 16234
4 ex10-1_001.jpg GRAPHIC 1037273
5 ex10-1_002.jpg GRAPHIC 1285078
6 ex10-1_003.jpg GRAPHIC 1203507
7 ex10-1_004.jpg GRAPHIC 1138260
8 ex10-1_005.jpg GRAPHIC 1056070
9 ex10-1_006.jpg GRAPHIC 1155983
10 ex10-1_007.jpg GRAPHIC 1292986
11 ex10-1_008.jpg GRAPHIC 1295917
12 ex10-1_009.jpg GRAPHIC 1165534
13 ex10-1_010.jpg GRAPHIC 1258167
14 ex10-1_011.jpg GRAPHIC 1127311
15 ex10-1_012.jpg GRAPHIC 959399
16 ex10-1_013.jpg GRAPHIC 272228
17 ex99-1_001.jpg GRAPHIC 9952
  Complete submission text file 0001493152-23-027122.txt   19893911

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE pcsa-20230808.xsd EX-101.SCH 3060
19 XBRL LABEL FILE pcsa-20230808_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE pcsa-20230808_pre.xml EX-101.PRE 22389
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 231149779
SIC: 2834 Pharmaceutical Preparations